Examining the value of pharmacy benefit management companies

American Journal of Health-System Pharmacy

Volumn 61, Issue 1, 2004, Pages 81-85

  Garis, Robert I ^a   Clark, Bartholomew E ^a   Siracuse, Mark V ^a   Makoid, Michael C ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG;

DECISION MAKING; DRUG COST; DRUG UTILIZATION; EDUCATION PROGRAM; HEALTH CARE; HEALTH CARE FINANCING; HEALTH INSURANCE; NOTE; PATIENT SATISFACTION; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; ARTICLE; FINANCIAL MANAGEMENT; INSURANCE; ORGANIZATION AND MANAGEMENT;

CONTRACT SERVICES; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; UNITED STATES;

EID: 1642446117     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.1.81     Document Type: Note

References (35)

1. Kowalczyk L. Spending on health care rises 7 percent. Boston Globe. 2002; Jan 8.
2. Martinez B. Health costs seen rising feverishly. Wall St J. 2001; Dec 10.
3. Silber J. Firms pass the buck on health care. Contra Costa Times. 2001; Dec 10.
4. Lundy J, Levitt L, eds. Prescription drug trends-a chartbook. Menlo Park, CA: Kaiser Family Foundation; 2000.
5. Taniguchi R. Pharmacy benefit management companies. Am J Health-Syst Pharm. 1997; 52:1915-7.
6. Garis RI, Clark BE, Makoid MC. Restructure PBM incentives to boost cost savings. Bus Insur. 2002; 36(39):10.
7. McDonough K, Chandor C. New goals needed for pharmacy benefits. Drug Benefit Trends. 2001; 15(9):43-52.
8. Motheral BR, Fairman KA. Effect of a three-tier copay on pharmaceutical and other medical utilization. Med Care. 2001; 39:1293-304.
9. Segedin DA. Three tier copayment plans: design considerations and effectiveness. Drug Benefit Trends. 1999; 11(9):43-52.
10. Kritz FL. Stepping-up drug costs: insurers boost co-pays on many costly name brands. Wash Post. 2001; Nov 6:HE01.
11. Zitlow K, Zagata-Meraz S. Double-digit health care cost increases expected to continue in 2002. Linconshire, IL: Hewit Associates; 2001 Oct 29.
12. Freudenheim M. Drug middlemen are facing pressure over rising prices. N Y Times. 2002; Jan 5.
13. Examining PBMs: PBMs redefine their role in the wake of class-action lawsuits and a slightly skeptical payer community. Manag Healthc Exec. 2002; 12(3):25-9.
14. Pear R. Drug discount cards give the elderly small savings. N Y Times. 2002; Jan 4.
15. Saul A. More health plans question PBM effectiveness. Drug Top. 2001; 145(12):40-1.
16. Kowalczyk L. States mobilizing to lower drug costs. Boston Globe. 2003; Jan 15.
17. Gold R. Drug-benefits managers come under fire, as pharmacists push states for regulation. Wall St J. 2001; Sep 5.
18. Carillo P, Koepelman R. Organization structure and productivity: effect of subunit size, vertical complexity, and administrative intensity on operating efficiencies. Group Organ Stud. 1991; 16:44-59.
19. Abramawitz P. Controlling financial variables - purchasing, inventory control and waste reduction. Am J Hosp Pharm. 1984; 41:309-17.
20. Donohue T, Sprouse C. Drug formularies and the pharmaceutical industry - thriving in the managed care era. Waltham, MA: Parelel Consultants; 1995:18-23,29-33,48-55,57,63-9,88-91,94-7.
21. Navarro RP. The future of managed care drug formularies. Med Interface. 1994; 7(4):62-4.
22. GAO study of pharmacy benefit managers (PBMs) ignores facts with unbalanced, misleading analysis. Alexandria, VA: National Association of Chain Drug Stores; 2003 Oct 1.
23. Fritz S. Billions in drugmaker rebates diverted. St Petersburg Times. 2002; Dec 10:1E.
24. Quinn RD. A prescription for failure? Employee Benefits News. 2002; Sep 15.
25. Freudenheim M. Pharmacy benefit companies won't disclose fees. N Y Times. 2003; Jan 10:C3.
26. Kabler P. Drug provider took West Virginia for millions, lawsuit alleges. Charleston Gaz. 2002; Nov 14.
27. Mercer Human Resource Consulting. Navigating the pharmacy benefits marketplace. Oakland, CA: California Health Care Foundation; 2003.
28. Barnes JE. When is a rebate a kickback? U S News World Rep. 2002; 133(6):31.
29. Johnson RS. Ripe for regulation. Food Drug Law J. 2002; 57:1-46.
30. Martin SS. PBM industry today: who's managing drug costs? Manag Care Mag. 2001; 10(12).
31. Kaupp GS. Were health plans better off before electronic claims processing? Manag Care Interface. 2001; 14(11):41-2.
32. Wilson P. Defining and shaping financing needs. In: Wertheimer AI, Navarro RP, eds. Managed care pharmacy: principles and practice. New York: Pharmaceutical Products; 1999:63-81.
33. Schafermeyer KW. Private health insurance. In: McCarthy R, Schafermeyer KW, eds. Introduction to health care delivery: a primer for pharmacists. Gaithersburg, MD: Aspen Publishers; 2001:453-78.
34. Price alert - the official guide to AWP pricing. Price Alert. 2003; 15(1):1-76.
35. Pugh T. A system to save on drugs falters. Phila Inq. 2003; Feb 10.